Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia

Oncologist

Volumn 18, Issue 7, 2013, Pages 885-891

  Komen, Manon M C ^a   Smorenburg, Carolien H ^a   van den Hurk, Corina J G ^b   Nortier, Johan W R ^c  

^a Medical Centre Alkmaar   (Netherlands)

^b The Netherlands   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alopecia; Chemotherapy; Scalp cooling; Side effects

Indexed keywords

BLEOMYCIN; BUSULFAN; CABAZITAXEL; CARBOPLATIN; CATUMAXOMAB; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IDARUBICIN; IFOSFAMIDE; IRINOTECAN; IXABEPILONE; LOMUSTINE; METHOTREXATE; MITOMYCIN; NAVELBINE; OXALIPLATIN; PACLITAXEL; PANITUMUMAB; PROCARBAZINE; TOPOTECAN; TRASTUZUMAB; UNINDEXED DRUG; ANTINEOPLASTIC AGENT;

ALOPECIA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CLAUSTROPHOBIA; CLINICAL EFFECTIVENESS; COLD; COLON CANCER; CONTROLLED STUDY; COOLING; CRYOGEL; DEVICE THERAPY; DISEASE SEVERITY; FEMALE; HEADACHE; HUMAN; LITERATURE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; OVARY CANCER; PERFUSION; PRIORITY JOURNAL; SCALP COOLING; SENSATION; SKIN TEMPERATURE; CHEMICALLY INDUCED; DRUG THERAPY; INDUCED HYPOTHERMIA; META ANALYSIS; NEOPLASMS; PATHOLOGY; SCALP; TREATMENT OUTCOME;

ALOPECIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG THERAPY; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; NEOPLASMS; SCALP; TREATMENT OUTCOME;

EID: 84880686879     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0332     Document Type: Article

References (43)

1. Giaccone G, Di Giulio F, Morandini MP et al. Scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer Nurs 1988;11:170-173.
2. Hunt JM, Anderson JE, Smith IE. Scalp hypothermia to prevent adriamycin-induced hair loss. Cancer Nurs 1982;5:25-31.
3. Mols F, van den Hurk CJ, Vingerhoets AJ et al. Scalp cooling to prevent chemotherapyinduced hair loss: Practical and clinical considerations. Support Care Cancer 2009;17:181-189.
4. Rosman S. Cancer and stigma: Experience of patients with chemotherapy-induced alopecia. Patient Educ Couns 2004;52:333-339.
5. Van den Hurk CJ, Mols F, Vingerhoets AJ et al. Impact of alopecia and scalp cooling on the wellbeing of breast cancer patients. Psychooncology 2010;19:701-709.
6. Batchelor D. Hair and cancer chemotherapy: Consequences and nursing care-A literature study. Eur J Cancer Care (Engl) 2001;10: 147-163.
7. Hesketh PJ, Batchelor D, Golant M et al. Chemotherapy-induced alopecia: Psychosocial impact and therapeutic approaches. Support Care Cancer 2004;12:543-549.
8. Botchkarev VA, Komarova EA, Siebenhaar F et al. p53 is essential for chemotherapy-induced hair loss. Cancer Res 2000;60:5002-5006.
9. Trueb RM. Chemotherapy-induced hair loss. Skin Therapy Lett 2010;15:5-7.
10. Trueb RM. Chemotherapy-induced alopecia. Semin Cutan Med Surg 2009;28:11-14.
11. Grevelman EG, Breed WP. Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol 2005;16:352-358.
12. Lemenager M, Lecomte S, Bonneterre ME et al. Effectiveness of cold cap in the prevention of docetaxel-induced alopecia. Eur J Cancer 1997;33: 297-300.
13. Munstedt K, Manthey N, Sachsse S et al. Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer 1997;5:139-143.
14. Breed W, van den Hurk CJ, Peerbooms M. Presentation, impact and prevention of chemotherapy induced hair loss: Scalp cooling potentials and limitations. Dermatology 2011;6:109-125.
15. Van den Hurk CJ, Peerbooms M, van de Poll-Franse LV et al. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients: Results of the Dutch Scalp Cooling Registry. Acta Oncol 2012;51:497-504.
16. Janssen FE, van Leeuwen GM, van Steenhoven AA. Modelling of temperature and perfusion during scalp cooling. Phys Med Biol 2005;50: 4065-4073.
17. Wheelock JB, Myers MB, Krebs HB et al. Ineffectiveness of scalp hypothermia in the prevention of alopecia in patients treated with doxorubicin and cisplatin combinations. Cancer Treat Rep 1984;68: 1387-1388.
18. Adams L, Lawson N, Maxted KJ et al. The prevention of hair loss from chemotherapy by the use of cold-air scalp-cooling. Eur J Cancer Care (Engl) 1992;1:16-18.
19. Auvinen PK, Mahonen UA, Soininen KM et al. The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia. Tumori 2010; 96:271-275.
20. Macduff C, Mackenzie T, Hutcheon A et al. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. Eur J Cancer Care (Engl) 2003;12:154-161.
21. Satterwhite B, Zimm S. The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer 1984;54:34-37.
22. Tollenaar RA, Liefers GJ, Repelaer van Driel OJ et al. Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer. Eur J Cancer 1994;30A:1448-1453.
23. Anderson JE, Hunt JM, Smith IE. Prevention of doxorubicin-induced alopecia by scalp cooling in patients withadvancedbreast cancer. Br Med J (Clin Res Ed) 1981;282:423-424.
24. David J, Speechley V. Scalp cooling to prevent alopecia. Nurs Times 1987;83:36-37.
25. Robinson MH, Jones AC, Durrant KD. Effectiveness of scalp cooling in reducing alopecia caused by epirubicin treatment of advanced breast cancer. Cancer Treat Rep 1987;71:913-914.
26. Symonds RP, McCormick CV, Maxted KJ. Adriamycin alopecia prevented by cold air scalp cooling. Am J Clin Oncol 1986;9:454-457.
27. Vendelbo JL. Scalp hypothermia in the prevention of chemotherapy-induced alopecia. Acta Radiol Oncol 1985;24:113-116.
28. Gregory RP, Cooke T, Middleton J et al. Prevention of doxorubicin-induced alopedia by scalp hypothermia: Relation to degree of cooling. Br Med J (Clin Res Ed) 1982;284:1674.
29. Bulow J, Friberg L, Gaardsting O et al. Frontal subcutaneous blood flow, and epi-and subcutaneous temperatures during scalp cooling in normal man. Scand J Clin Lab Invest 1985;45:505-508.
30. Hillen HF, Breed WP, Botman CJ. Scalp cooling by cold air for the prevention of chemotherapy-induced alopecia. Neth J Med 1990;37:231-235.
31. Janssen FP, Rajan V, Steenbergen W et al. The relationship between local scalp skin temperature and cutaneous perfusion during scalp cooling. Physiol Meas 2007;28:829-839.
32. Middleton J, Franks D, Buchanan RB et al. Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine. Cancer Treat Rep 1985;69:373-375.
33. Kargar M, Sarvestani RS, Khojasteh HN et al. Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy. J Adv Nurs 2011;67:2473-2477.
34. Dean JC, Griffith KS, Cetas TC et al. Scalp hypothermia: Acomparison of ice packsandthe Kold Kap in the prevention of doxorubicin-induced alopecia. J Clin Oncol 1983;1:33-37.
35. Katsimbri P, Bamias A, Pavlidis N. Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur J Cancer 2000;36: 766-771.
36. Ridderheim M, Bjurberg M, Gustavsson A. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: A pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer 2003;11:371-377.
37. Christodoulou C, Klouvas G, Efstathiou E et al. Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia. Oncology 2002;62:97-102.
38. Komen MMC, Smorenburg CH, Breed WPM et al. Optimal pre-infusion cooling time in patients treated with chemotherapy and scalp cooling. Eur J Cancer 2011;47:S320.
39. Van den Hurk CJ, Breed WP, Nortier JW. Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 2012;20:3255-3260.
40. Guy R, Shah S, Parker H et al. Scalp cooling by thermocirculator. Lancet 1982;1:937-938.
41. Peck HJ, Mitchell H, Stewart AL. Evaluating the efficacy of scalp cooling using the Penguin cold cap system to reduce alopecia in patients undergoing chemotherapy for breast cancer. Eur J Oncol Nurs 2000;4:246-248.
42. Massey CS. A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy. Eur J Oncol Nurs 2004;8:121-130.
43. Coukell AJ, Faulds D. Epirubicin. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of breast cancer. Drugs 1997;53: 453-482.